pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Nephrology · news · pharmadog
← back to Nephrology
News · Nephrology
282
stories
Sep 28, 26
Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
biospace
Sep 25, 26
How NIH’s Nicole Kleinstreuer is working to reduce animal testing while avoiding a ‘backlash’
fiercebiotech
Sep 25, 26
Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches
fiercebiotech
Sep 25, 26
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
biopharma dive
Sep 25, 26
Merck expands Welireg's use to broader set of kidney cancer patients
endpoints
Sep 25, 26
Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
biospace
Sep 25, 26
ADARx scores upsized $446M IPO, while fellow RNA biotech City maps out Nasdaq plans
fiercebiotech
Sep 25, 26
RNAi drug specialist ADARx raises $446M IPO
biopharma dive
Sep 24, 26
Chutes & Ladders—Travere chief makes way for former Amicus CEO
fiercebiotech
Sep 24, 26
Lilly’s latest China drug deal; Immunovant’s setback in lupus
biopharma dive
Sep 24, 26
Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs
biospace
Sep 24, 26
Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
fiercebiotech
Sep 23, 26
Berlin Seeds Recalls Alfalfa Sprouting Seed Because of Possible Health Risk
fda recalls
Sep 23, 26
Roche, Ionis RNA drug scores in kidney disease study
biopharma dive
Sep 23, 26
Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
biospace
Sep 23, 26
Ionis-Otsuka offer 'groundbreaking' improvement in function and survival for genetic type of ALS
biospace
Sep 23, 26
Roche kidney drug's Phase 3 win sets up path to accelerated approval
endpoints
Sep 23, 26
Roche’s phase 3 win tees up fight with Novartis for blockbuster kidney disease market
fiercebiotech
Sep 22, 26
Vertex aims for broad kidney disease label ahead of key readout next year
endpoints
Sep 22, 26
Vertex opens up larger kidney disease opportunity with mid-stage readout
biospace
Sep 22, 26
2026 IPO blitz continues with 4 new biotech filings
biospace
Sep 22, 26
New federal autism committee head has financial ties to leucovorin
stat
Sep 22, 26
Vertex’s midstage data amplify kidney disease market opportunity
fiercebiotech
Sep 21, 26
Otsuka ICU Medical LLC Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection, USP Due To a Product Mix-up with 10 mEq Potassium Chloride Injection
fda medwatch
Sep 18, 26
Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope
fiercebiotech
Sep 17, 26
Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential
fiercebiotech
Sep 17, 26
STAT+: New startup to test psychedelic-like drug against Parkinson’s symptom
stat
Sep 16, 26
STAT+: Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding them
stat
Sep 16, 26
U.S. reaches highest number of measles deaths in decades
stat
Sep 15, 26
STAT+: Obesity drugmakers are testing in kids as young as 6
stat
← prev
page 4 of 10
next →